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Introduction: Depression and panic disorder are widely acknowledged as complicating
factors in asthma patients. However, their impact on health outcomes in primary care
patients is less well examined. This study prospectively evaluated the impact of depression
and panic disorder on outcomes of primary care patients with asthma over 1 year.
Methods: At baseline, 256 asthma patients from 43 primary care practices completed self-
report questionnaires including the Patient Health Questionnaire (PHQ), the Asthma
Quality of Life Questionnaire (AQLQ), and a structured questionnaire evaluating asthma
severity, hospitalisation and emergency visits. One year later, 185 (72.3%) patients
completed the same questionnaire.
Results: At baseline, 3.9% of patients suffered from major depressive disorder, 22.7% from
minor depressive disorder, and 7.8% from panic disorder. In the year under evaluation, 17
patients (9.2%) received emergency home visits and 10 patients (5.4%) were admitted to a
hospital. Depression at baseline predicted hospitalisation within the subsequent year (OR
6.1; 95% CI 1.5–24.6) and panic disorder predicted unscheduled emergency home visits (OR
4.8; 95% CI 1.3–17.7). Depression but not panic disorder predicted the AQLQ scales activity
(p ¼ 0.001), symptoms (p ¼ 0.001), emotions (p ¼ 0.001) and environment (p ¼ 0.001) at
follow-up.
Conclusions: Although rates of hospitalisation and emergency visits in primary care are
low, the impact of psychiatric comorbidity on health outcomes for patients with asthma is
substantial. It might be helpful to identify patients with psychiatric comorbidity by
analysing reasons for hospitalisation and emergency visits. For these patients, intensifyingElsevier Ltd. All rights reserved.
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utilisation and avoid adverse outcomes.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Asthma is a common chronic disease with a high prevalence
of approximately 5% in industrialised nations. It is char-
acterised by a chronic inflammation process which induces
bronchial hyper-responsiveness and reversible airway ob-
struction.1 Asthma is therefore acknowledged widely as an
organic disease. This cannot be taken for granted as it was
historically seen as a purely psychosomatic disease.2 Since
then, more complex models have emerged which describe
asthma as an organic disease with a high vulnerability to
psychological influences.2,3 It was demonstrated using a
telephone survey that asthma patients had a higher risk for
anxiety or depression.4 A high psychiatric comorbidity was
shown especially for patients with severe or difficult
asthma.5,6 A recent cross-sectional survey showed an
association between depression and lifetime hospital visits
in asthma patients.7 In a prospective trial, anxiety/depres-
sion predicted a higher hospitalisation rate in patients
initially presenting with exacerbation of asthma or COPD.8
In contrast, Greaves et al. found in patients with recent
asthma attacks that low panic fear and high control
confidence was associated with an increased risk of asthma
attacks within 12 months.9 This was attributed to a lower
self-awareness with respect to the disease for these instable
patients. However, these prospective surveys were per-
formed with highly selected patients from emergency
departments or hospitals. Thus, the impact of psychiatric
comorbidity on the long-term outcome of patients with
asthma in primary care remains unclear. This is important,
as unselected patients in general practice present with all
levels of asthma severity, with a higher preponderance of
mild or moderate courses of disease10,11 which are influ-
enced by psychological factors to an unknown extent.
Therefore, the aim of this prospective study was to evaluate
the impact of depression and anxiety on health care
utilisation outcomes and quality of life in general practice
asthma patients over 1 year.
Methods
Study design
This longitudinal survey was performed in Saxony–Anhalt
with asthma patients from 46 general practices (GPs). The
participating general practices were involved in a quality
improvement project, which was financed by the Ministry of
Health (ISRCTN51102813).
Setting and patients
GPs were asked to hand out a questionnaire to each patient
with asthma coming for consultation between May and July
2005 (beginning of study, t1). All GPs were instructed via aleaflet to select patients on basis of previously performed
diagnostics such as spirometry or broncho-provocation.
Additionally, the most relevant criteria to distinguish
between asthma and COPD were explained in the leaflet,
e.g. they were instructed to preferably select patients with
varying symptoms, attacks of dyspnoea and wheezing or
with a known allergy. Heavy smokers likely to have COPD
were to be avoided. Patients were asked to complete the
questionnaire and to send it to the study centre, assuring
the anonymous handling of their data. Three prizes of 250h
were raffled as an incentive for the patients’ participation.
One year later, on 1 June 2006 (t2), the patients received
the same questionnaire posted from the study centre. Again,
three prizes of 250h were raffled as an incentive. Three
reminders were sent out after 4, 8 and 12 weeks. The study
was approved by the Medical Ethics Committee of the
Medical Faculty at the University of Heidelberg.Measures
The presence of major and minor depressive disorders as well
as panic disorder was established according to DSM-IV
diagnostic criteria using the validated German version of
the Patient Health Questionnaire (PHQ).12,13 The nine-item
depression module evaluates the presence of one of the nine
DSM-IV criteria for major depression. Major depression is
diagnosed when five or more questions are answered with
‘symptoms on more than half of the days’. Minor depression is
diagnosed when two, three or four questions are answered
with ‘symptoms on more than half of the days’. The question
‘Thoughts that you would be better off dead, or of hurting
yourself in some way?’ is included when the response ‘On
several days’ is endorsed. The panic disorder module
comprises five items. According to DSM-IV diagnostic algo-
rithms, panic disorder is diagnosed when all five PHQ items
are answered positively. Excellent operating characteristics
have been demonstrated for the American14,15 and German
versions of the PHQ.12,13 It has also been shown that the PHQ
diagnostic algorithms result in realistic estimates of base
rates for major depressive disorder, and panic disorder.16
With reference to a gold standard interview for mental
disorders, the sensitivity of the PHQ classification for major
depressive disorders is 83% and its specificity is 90%,13 for
panic disorder its sensitivity is 86% and its specificity is 91%.12
To determine the patients’ health-related quality of life,
the standardised German version of the ‘Asthma Quality of
Life Questionnaire’ (AQLQ) was used. The AQLQ, which has
strong measurement properties,17 has 32 items on a seven-
point scale and measures four dimensions of health-related
quality of life (QoL), namely activities, symptoms, emotions
and environment. These four dimensions are summarised in
an overall score. The range of all scales, including the sum
score, is from 1 (worst) to 7 (best), the minimal important
change is 0.5.18 The AQLQ measures have been shown to be
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Table 1 Baseline patient characteristics (n ¼ 256).
Age Mean (S.D.)
56.3 (16.4)
Asthma severity N (%)
Intermittent 59 (23.0)
Symptoms less than once a week
Mild persistent
Symptoms more than once a week,
less than once a day
63 (24.6)
Moderate persistent
Symptoms daily, but not continuously 92 (35.9)
Severe persistent
Symptoms continuously, limitation to
physical activities
19 (7.4)
Medication
Inhaled steroids 176 (68.8)
Oral steroids 21 (8.2)
Inhaled sympathomimetics 200 (78.1)
Full medication guideline adherence 103 (40%)
Medication guideline adherence, but
underdosing
80 (34%)
Inadequate medication 50 (21%)
Self management
Asthma education 69 (27.0)
Smoking 65 (25.4)
Psychiatric comorbidity (PHQ)
Major depression 10 (3.9)
Minor depression 58 (22.7)
Panic disorder 20 (7.8)
PHQ: Patient Health Questionnaire.
Predictors of health outcomes for asthma patients 361related to the clinical status of the asthma.19 Patients were
asked about their daily and nocturnal asthma-related
symptoms according to the international levels of asthma
severity (intermittent, mild persistent, moderate persis-
tent, severe persistent).20 Current medication including
dosage was documented by the patient in a structured
register. Additionally, patients were asked if they had been
admitted to hospital within the last 12 months due to their
asthma (if admitted: how many days in hospital) and if they
had received unscheduled home visits by a GP or ambulatory
care due to their asthma within the last 12 months (if
received: how often).
Analysis
Questionnaires were scanned and data were imported
automatically into SPSS 14.0 by Eyes & Handss Forms,
Version 5. Baseline data were presented descriptively.
Differences between females/males and responders/non-
responders were calculated using t- or w2-tests as appropriate.
To assess adherence to guidelines, each patient’s medication
was checked manually. Full adherence to guidelines implied
that the prescribed medication was consistent with the
guidelines and that the patient had intermittent or mild
persistent asthma for day and night.20 Full adherence was also
recorded when the patient suffered from moderate of severe
persistent asthma but received end-of-dose therapy such as
oral steroids. Guideline adherence, but under-dosing of
medication implied that a patient receiving appropriate
medication presented symptoms indicative of moderate or
severe persistent asthma such that the dose needed to be
increased. Inappropriate prescribing of medication implied
that the patient had not been treated according to guidelines,
e.g. if only sympathomimetics without steroids were pre-
scribed in mild, moderate or severe persistent asthma. Odds
ratios related to hospitalisation (yes/no) and unscheduled
emergency visits (yes/no) at follow-up were estimated with
univariate logistic regression using the diagnoses of any
depressive disorder (i.e. major and minor depressive disorder)
and panic disorder as independent variables. Odds ratios were
also calculated for asthma severity, sex, age, smoking habits,
inhaled steroids and inhaled sympathomimetics and medica-
tion guideline adherence in order to control for the factors
most affecting asthma outcome. A logistic regression model
(backward selection) was calculated with hospitalisation/
unscheduled emergency visits as dependent variables and
depression, anxiety, medication guideline adherence, sex, age
and smoking habits as independent variables to determine the
strongest predictors. An ANCOVA model with either depression
(t1) or panic disorder (t1) as covariate and severity of asthma
(t2) as a fixed factor was established to predict quality of life
at 12-month follow-up (t2). Medication guideline adherence,
sex, age and smoking habits were included as fixed factors to
control for the factors most relevant to asthma outcome.
Results
Baseline characteristics
A total of 314 patients received the questionnaire from their
GPs. Two hundred and fifty-six patients (response rate: 81.5%)sent back the questionnaire. One hundred and fifty-eight of
the responders were female (61.7%); and the average age
(S.D.) was 56.3 (16.4) years. At baseline, there was no
significant difference between responders and non-responders
with regard to age, sex and asthma severity (non-responder
analysis not in the table). Nearly half of the patients reported
symptoms corresponding to moderate or severe persistent
asthma as they had daily symptoms (Table 1). We found high
psychiatric comorbidity in the asthma patients with 7.8%
suffering from panic disorder and 26.6% fulfilling the criteria
for major or minor depressive disorders. We found no
difference between depressed and non-depressed patients
with respect to age (p ¼ 0.192; t-test) or sex (p ¼ 0.194; w2-
test). The use of steroids was relatively high, with 68.8%
receiving inhaled and 8.2% oral steroids. Only 27% of the
patients participated in an educational asthma program. Forty
percent received medication with full adherence to guidelines,
34% were treated according to guidelines, but with a dosage
which was too low and suffered from moderate or severe
asthma. Twenty-one percent received inadequate medication.Twelve month follow-up
One hundred and eighty-five patients (72.3%) responded
to the follow-up survey 1 year later. The responders and
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to sex and age. There was also no significant difference with
respect to asthma severity at t1 between responders and
non-responders at follow-up (p ¼ 0.12 in w2-test; not shown
in the table). Quality of life declined and depression
increased with asthma severity (Table 2). The ANOVA was
significant with respect to these differences. Asthma
severity improved moderately from t1 to t2. This might be
due to the GPs meetings in quality circles, where they
attended educational meetings to reflect optimal asthma
care under the guidance of a trained facilitator.21 However,
there were no significant changes in quality of life and
depression scores within 1 year.Predictors of hospitalisation and unscheduled
emergency visits by GPs at 12 months
Ten patients were hospitalised during the 1-year follow-up
time, with an average length of stay of 15.2 days (S.D. 12.5;
min 1; max 40), eight were male (12% of all males) and two
were female (2% of all females). Seventeen patients
received unscheduled emergency visits from their GPs, withTable 2 Quality of life and depression scores at baseline (t1)
Asthma severity t1
N (%) AQLQ,
Mean (S.D.)
Depressi
Mean (S.
Intermittent 46 (24.9) 5.48 (0.96) 4.20 (3.6
Mild persistent 40 (21.6) 4.64 (0.94) 5.64 (4.0
Moderate
persistent
73 (39.5) 3.81 (0.98) 7.59 (4.9
Severe persistent 15 (8.1) 3.20 (0.78) 8.33 (4.3
Sum 174 (94.1) 4.44 (1.23) 6.17 (4.6
AQLQ: Asthma Quality of Life Questionnaire; PHQ: Patient Health Qu
Quality of life scores differ significantly between the different a
yDepression scores (PHQ) differ significantly between the differen
Table 3 Predictors of hospitalisation and unscheduled emerg
regression analyses).
Predictor Hospitalisation
OR 95% C
Depressive disorder t1 (PHQ) (yes/no) 6.1 1.5–2
Panic disorder t1 (PHQ) (yes/no) 3.5 0.7–1
Asthma severity t1 2.6 1.1–6
Inhaled steroids 1.5 0.3–7
Inhaled sympathomimetics 2.0 0.2–1
Guideline adherence of medication (yes/no) 0.6 0.1–2
Gender 7.4 1.5–3
Age 1.0 0.9–1
Smoking 1.2 0.3–5
Asthma education (yes/no) 2.3 0.6–8
PHQ: Patient Health Questionnaire; depressive disorder is both minoan average frequency of 3.1 (S.D. 2.50; min 1, max 10).
Hospitalisation was predicted by depressive disorder, asth-
ma severity at t1 and sex (Table 3). The logistic regression,
including interaction analysis showed no interaction be-
tween asthma severity and depressive disorder. There was
also no significant interaction between sex and asthma
severity, depression, anxiety, medication guideline adher-
ence or smoking. In the logistic regression model (backward
selection), which controlled for medication guideline
adherence, smoking, age and sex, only depressive disorder
(p ¼ 0.009) and sex (p ¼ 0.008) remained significant pre-
dictors for hospitalisation (data not in table). Unscheduled
emergency visits were predicted by panic disorder at t1,
asthma severity and medication guideline adherence
(Table 3). The logistic regression with interaction analysis
showed no interaction between asthma severity and panic
disorder. In the logistic regression model (backward selec-
tion), which controlled for medication guideline adherence,
smoking, age and sex, only panic disorder remained a
significant predictor for unscheduled emergency visits
(p ¼ 0.050). Besides that, patients with asthma education
had more emergency visits (p ¼ 0.024). Indeed patients with
asthma education also suffered from more unfavourableand follow-up (t2) (n ¼ 185).
t2
on,y
D.)
N (%) AQLQ,
Mean (S.D.)
Depression,y
Mean (S.D.)
4) 47 (25.4) 5.62 (0.96) 3.83 (3.88)
5) 54 (29.2) 4.58 (0.86) 6.74 (5.21)
0) 58 (31.4) 3.65 (1.0) 8.31 (5.10)
5) 19 (10.3) 3.16 (0.84) 9.38 (4.92)
5) 178 (96.2) 4.47 (1.30) 6.59 (5.17)
estionnaire.
sthma severities (F ¼ 50.1; po0.001).
t asthma severities (F ¼ 9.6; po0.001).
ency visits within following 12 months (univariate logistic
(yes/no) (t2) Emergency visit (yes/no) (t2)
I p OR 95% CI p
4.6 0.011 1.7 0.6–4.9 0.295
8.3 0.145 4.8 1.3–17.7 0.019
.2 0.035 3.5 1.6–7.5 0.001
.2 0.629 1.2 0.4–3.9 0.769
6.6 0.509 3.7 0.5–29.1 0.213
.3 0.426 0.2 0.1–0.9 0.033
6.2 0.013 1.2 0.4–3.4 0.690
.1 0.592 1.0 0.9–1.0 0.781
.0 0.776 1.2 0.4–3.6 0.752
.2 0.211 3.4 1.2–9.7 0.024
r and major depression.
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in table).
Predictors of quality of life at 12 months
The ANCOVA with depression (t1) as covariate and asthma
severity (t2), medication guideline adherence (t2), smoking
habits (2), age and sex as a fixed factors showed a significant
influence of depression (t1) and asthma severity (t2) on the
scales of the AQLQ (Table 4 and Figure 1). The other control
factors did not show any influence with the exception of a
negative correlation between age and activity (p ¼ 0.005).
Panic disorder (t1) had no significant influence on the AQLQ
scales. The asthma severity at t2 was the strongest predictor
for quality of life. As illustrated in Figure 1, patients with
depression at t1 reported lower health-related quality of life
across all asthma severities at t2.
Discussion
Our study identified depression as a predictor of hospitalisa-
tion and panic disorder as a predictor of unscheduled
emergency visits in primary care patients with asthma.
Depression but not panic disorder at baseline predicted
quality of life at follow-up.
Depression in particular is known as a predictor of health
outcomes in several conditions such as cerebrovascular
disease,22 coronary heart disease,23 and diabetes.24 Its
ability to influence somatic conditions also draws attention
to asthma.3,25,26 The origin of the independent predictive
value of depression in our study remains speculative.
Depressive symptoms were found to be a reason for poor
adherence to asthma therapy,26–28 which might lead to a
higher hospital admission rate. A meta-analysis revealed
that there might be a general relation between depression
and poor adherence to therapy in chronically ill patients,
which could be due to reduced cognitive functioning,
negative expectations about the benefits of treatment and
lower social support.29 Besides that, it is speculated that
depression itself could have a direct effect on airway
instability and asthma exacerbation by directly influencing
vagal activity30 or its influence could be mediated by
pathway defects in the function of the autonomic nervous
system.31
Similar pathophysiologic pathways are known with regard
to the course of disease in asthma and panic disorder31; andTable 4 Predictors of quality of life (ANCOVA with asthma
covariates).
Predictor Activity t2 Sy
F p F
Depressive disorder t1 (PHQ) (yes/no) 12.14 0.001 11
Asthma severity t2 31.99 o0.001 42
Panic disorder t1 (PHQ) (yes/no) 0.23 0.880
Asthma severity t2 38.02 o0.001 49
PHQ: Patient Health Questionnaire; depressive disorder is both minothe relation between panic disorder and asthma is a well-
known phenomenon.33,34 Consistent with these previous
findings, the prevalence of 7.8% of patients suffering from
panic disorder in our study is much higher than in the
general population (1.5%)35 and comparable with prevalence
rates in patients with pulmonary hypertension36 and the
results of an epidemiologic asthma survey.37 We found that
the presence of panic disorder had a strong and independent
impact on unscheduled emergency visits by patients.
A vicious cycle linking asthma severity, experience of asthma
attacks and subsequent conditioning with hyperventilation
and other panic symptoms,32,38 might be responsible for
frequent utilisation of home/emergency visits. Interestingly,
Kullowatz et al. also found hospitalisation to be related to
depression but not panic disorder in their cross-sectional
survey.7 However, this was based on retrospective lifetime
hospital visits. It could be hypothesised that patients with
panic disorders are treated by their GPs who prevent
hospitalisation with their interventions. This might explain
why we could not find panic disorder to influence hospita-
lisation. The strong influence of sex on hospitalisation
remains unclear as there was no association with other
factors such as depression, asthma severity or smoking. The
evidence for the influence of sex on the course of disease is
increasing39 and was already found in COPD40,41 and
cardiovascular diseases.42,43 Our study indicates that asthma
might be more prevalent in women and suggests the
presence of sex differences in morbidity risk for this disease
as well. However, these results are due to secondary
analyses. Therefore, further surveys including sex-related
analyses would be necessary to confirm our findings. The
positive association between asthma education and un-
scheduled emergency visits might be explained by the more
unfavourable asthma severity of these patients.
Another important finding is that depression at baseline
predicted quality of life at follow up, whereas panic disorder
had no influence on this variable. Rimington et al.
demonstrated the complex relation between depression,
anxiety and asthma morbidity.25 They found that depression
and anxiety scores could help to explain symptoms over and
above the effects of lung function. They concluded that
reported symptoms may reflect not only ‘hard measures’
like FEV1 but also non-asthma factors. Rosenzweig et al. also
found that objective FEV1 measures do not fully account for
health related quality of life.44
Therefore, quality of life needs to be interpreted not only
based on ‘somatic’ asthma severity but also based onseverity at t2 as fixed factor and depression/anxiety as
mptoms t2 Emotions t2 Environment t2
p F p F p
.25 0.001 6.96 0.009 10.11 0.002
.82 o0.001 35.99 o0.001 27.20 o0.001
0.024 0.876 0.84 0.360 0.165 0.685
.24 o0.001 39.64 o0.001 31.88 o0.001
r and major depression.
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Figure 1 Scales of the Asthma Quality of Life Questionnaire (AQLQ) at follow up (t2) in patients with or without depression at
baseline (t1). Values are mean (S.E.M.).
A. Schneider et al.364psychiatric comorbidity, in terms of depression. It remains
to discuss why we did not find a relation between panic
disorder and quality of life. An explanation might be that we
used a diagnostic algorithm for panic disorder and did not
use anxiety severity scores like other authors.7,25
A limitation of our findings was the low rate of
hospitalisation, thus resulting in wide confidence intervals.
This reflects reality in primary care, where the severity of a
disease is generally lower than in specialised treatment
settings,45 which have also been shown to apply to asthma.11
On the other hand, our results remain significant. Another
aspect which could violate the generalisability of our study
is the selection of patients. However, the responders andnon-responders at follow-up did not differ with respect to
asthma severity and the response rate was still 72%.
Therefore, it seems unlikely that our results may over-
estimate the effect of depression and panic disorder. A
further limitation of the study is that outcomes were
completely based on patients self-reports. Although it has
already been proven that the PHQ diagnostic algorithms
result in realistic estimates for mood disorders, a standar-
dised clinical interview would be a ‘‘gold standard’’ to
confirm psychiatric diagnoses.13 However, this was not
possible due to the study design with the investigation of
patients from 43 practices distributed over a broad area.
Due to organisational reasons it was also impossible to
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Indeed, self-report information may be subject to recall
bias. Another limitation of the study is that we accepted
physicians’ diagnoses without confirming them by broncho-
provocation or by testing bronchodilator reversibility.
However, the high number of patients taking steroids, which
reflects ideal asthma therapy,1 and the low number of
smokers might indicate that we generated a coherent
population. Nevertheless, if there were an overlap with
COPD, the impact of psychiatric comorbidity remains
substantial on this patient group.
Our findings highlight the impact of psychiatric comorbid-
ity on asthma patient management in primary care. It could
be worthwhile to focus not only on the somatic part of the
disease but also to take into account the consequences of
depression and panic disorder. However, it seems to be a
challenge to address the needs of difficult asthma patients.
One initial step to improving care could be to identify
patients with high psychological comorbidity by analysing
reasons for hospitalisation and emergency visits. In addition,
psychotherapeutic or psychopharmacological treatment
could be initiated. This might help to reduce unnecessary
health care utilisation and to avoid associated potential
harmful side effects (e.g. nosocomial infection in hospital or
tachyarrhythmia due to intravenous theophylline). Finally,
identification of these difficult patients could help physi-
cians understand difficult doctor–patient interactions in
situations where repeated home visits are requested with
high emotional pressure. Therefore, actively involving the
patients in order to facilitate empowerment could help both
patients and doctors. Further research is necessary to find
optimal strategies to deal effectively with asthma patients
with high psychiatric comorbidity in general practice.
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